The Cerebellum

, Volume 12, Issue 4, pp 547–556 | Cite as

Reorganization of Circuits Underlying Cerebellar Modulation of Prefrontal Cortical Dopamine in Mouse Models of Autism Spectrum Disorder

  • Tiffany D. Rogers
  • Price E. Dickson
  • Eric McKimm
  • Detlef H. Heck
  • Dan Goldowitz
  • Charles D. Blaha
  • Guy Mittleman
Original Article


Imaging, clinical, and pre-clinical studies have provided ample evidence for a cerebellar involvement in cognitive brain function including cognitive brain disorders, such as autism and schizophrenia. We previously reported that cerebellar activity modulates dopamine release in the mouse medial prefrontal cortex (mPFC) via two distinct pathways: (1) cerebellum to mPFC via dopaminergic projections from the ventral tegmental area (VTA) and (2) cerebellum to mPFC via glutamatergic projections from the mediodorsal and ventrolateral thalamus (ThN md and vl). The present study compared functional adaptations of cerebello-cortical circuitry following developmental cerebellar pathology in a mouse model of developmental loss of Purkinje cells (Lurcher) and a mouse model of fragile X syndrome (Fmr1 KO mice). Fixed potential amperometry was used to measure mPFC dopamine release in response to cerebellar electrical stimulation. Mutant mice of both strains showed an attenuation in cerebellar-evoked mPFC dopamine release compared to respective wildtype mice. This was accompanied by a functional reorganization of the VTA and thalamic pathways mediating cerebellar modulation of mPFC dopamine release. Inactivation of the VTA pathway by intra-VTA lidocaine or kynurenate infusions decreased dopamine release by 50 % in wildtype and 20–30 % in mutant mice of both strains. Intra-ThN vl infusions of either drug decreased dopamine release by 15 % in wildtype and 40 % in mutant mice of both strains, while dopamine release remained relatively unchanged following intra-ThN md drug infusions. These results indicate a shift in strength towards the thalamic vl projection, away from the VTA. Thus, cerebellar neuropathologies associated with autism spectrum disorders may cause a reduction in cerebellar modulation of mPFC dopamine release that is related to a reorganization of the mediating neuronal pathways.


Autism spectrum disorders Cerebellum Prefrontal cortex Dopamine Fragile X Lurcher 



The authors wish to thank Tom Schneider for technical assistance with these experiments. This work was supported by a grant from the National Institute of Neurological Disorders and Stroke (R01 NS063009).

Conflicts of interest

There is no conflict of interest, financial or otherwise, that might bias this work.


  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders-IV-TR. 4th ed. Washington: American Psychiatric Association; 2000.Google Scholar
  2. 2.
    Ozonoff S, South M, Provencal S. Executive functions in autism: Theory and practice. In Pérez JM, González PM, Comí MC, et al., editors. New developments in autism: the future is today. Philadelphia: Asociación de Padres de Personas con Autismo; 2007. pp 185–213.Google Scholar
  3. 3.
    Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AES. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003;61:181–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012;22:229–37.PubMedCrossRefGoogle Scholar
  5. 5.
    Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37:489–97.PubMedCrossRefGoogle Scholar
  6. 6.
    Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004;113:472–86.CrossRefGoogle Scholar
  7. 7.
    Rodier PM. Converging evidence for brain stem injury in autism. Dev Psychopathol. 2002;14:537–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Bauman ML. Microscopic neuroanatomic abnormalities in autism. Pediatrics. 1991;87:791–6.PubMedGoogle Scholar
  9. 9.
    Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol. 1997;7:269–78.PubMedCrossRefGoogle Scholar
  10. 10.
    Courchesne E, Townsend J, Akshoomoff NA, Saitoh O, Yeung-Courchesne R, Lincoln AJ, et al. Impairment in shifting attention in autistic and cerebellar patients. Behav Neurosci. 1994;108:848–65.PubMedCrossRefGoogle Scholar
  11. 11.
    Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988;318:1349–54.PubMedCrossRefGoogle Scholar
  12. 12.
    DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006;26:6897–906.PubMedCrossRefGoogle Scholar
  13. 13.
    Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain. 2004;127:2572–83.PubMedCrossRefGoogle Scholar
  14. 14.
    Webb SJ, Sparks BF, Friedman SD, Shaw DW, Giedd J, Dawson G, et al. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res. 2009;172:61–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci. 2005;23:183–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain. 1998;121:889–905.PubMedCrossRefGoogle Scholar
  17. 17.
    Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Caddy KW, Biscoe TJ. Structural and quantitative studies on the normal C3H and Lurcher mutant mouse. Philos Trans R Soc Lond. 1979;287:167–201.CrossRefGoogle Scholar
  19. 19.
    Zuo J, De Jager PL, Takahashi KA, Jiang W, Linden DJ, Heintz N. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature. 1997;388:769–73.PubMedCrossRefGoogle Scholar
  20. 20.
    Goldowitz D, Moran H, Wetts R. Mouse chimeras in the study of genetic and structural determinants of behavior. In: Goldowitz D, Wahlsten D, Wimer RE, editors. Techniques for the genetic analysis of brain and behavior: focus on the mouse. Amsterdam: Elsevier; 1992. p. 271–90.Google Scholar
  21. 21.
    Martin LA, Goldowitz D, Mittleman G. Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism. Eur J Neurosci. 2010;31:544–55.PubMedCrossRefGoogle Scholar
  22. 22.
    Dickson PE, Rogers TD, Del Mar N, Martin LA, Heck D, Blaha CD, et al. Behavioral flexibility in a mouse model of developmental cerebellar Purkinje cell loss. Neurobiol Learn Mem. 2010;94:220–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Mittleman G, Goldowitz D, Heck DH, Blaha CD. Cerebellar modulation of frontal cortex dopamine efflux in mice: relevance to autism and schizophrenia. Synapse. 2008;62:544–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Forster GL, Blaha CD. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur J Neurosci. 2003;17:751–62.PubMedCrossRefGoogle Scholar
  25. 25.
    Garcia-Rill E, Skinner RD, Miyazato H, Homma Y. Pedunculopontine stimulation induces prolonged activation of pontine reticular neurons. Neuroscience. 2001;104:455–65.PubMedCrossRefGoogle Scholar
  26. 26.
    Perciavalle V, Berretta S, Raffaele R. Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat. Neuroscience. 1989;29:109–19.PubMedCrossRefGoogle Scholar
  27. 27.
    Schwarz C, Schmitz Y. Projection from the cerebellar lateral nucleus to precerebellar nuclei in the mossy fiber pathway is glutamatergic: a study combining anterograde tracing with immunogold labeling in the rat. J Comp Neurol. 1997;381:320–34.PubMedCrossRefGoogle Scholar
  28. 28.
    Snider RS, Maiti A, Snider SR. Cerebellar pathways to ventral midbrain and nigra. Exp Neurol. 1976;53:714–28.PubMedCrossRefGoogle Scholar
  29. 29.
    Del Arco A, Mora F. Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat. J Neural Transm. 2005;112:97–109.PubMedCrossRefGoogle Scholar
  30. 30.
    Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci. 2001;21:700–12.PubMedGoogle Scholar
  31. 31.
    Pinto A, Jankowski M, Sesack SR. Projections from the paraventricular nucleus of the thalamus to the rat prefrontal cortex and nucleus accumbens shell: ultrastructural characteristics and spatial relationships with dopamine afferents. J Comp Neurol. 2003;459:142–55.PubMedCrossRefGoogle Scholar
  32. 32.
    Rogers TD, Dickson PE, Heck DH, Goldowitz D, Mittleman G, Blaha CD. Connecting the dots of the cerebro-cerebellar role in cognitive function: neuronal pathways for cerebellar modulation of dopamine release in the prefrontal cortex. Synapse. 2011;65:1204–12.PubMedCrossRefGoogle Scholar
  33. 33.
    Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, et al. Adult female fragile X permutation carriers exhibit age- and CGG repeat length-related impairments on an attentionally based enumeration task. Front Hum Neurosci. 2011;5:63.PubMedCrossRefGoogle Scholar
  34. 34.
    Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905–14.PubMedCrossRefGoogle Scholar
  35. 35.
    Ellegood J, Pacey LK, Hampson DR, Lerch JP, Henkelman RM. Anatomical phenotyping in a mouse model of Fragile X syndrome with magnetic resonance imaging. NeuroImage. 2010;53:1023–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Koekkoek SK, Yamaguchi K, Milojkovic BA, Dortland BR, Ruigrok TJ, Maex R, et al. Deletion of Fmr1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron. 2005;47:339–52.PubMedCrossRefGoogle Scholar
  37. 37.
    Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic; 2001.Google Scholar
  38. 38.
    Linnemann C, Sultan F, Pedroarena CM, Schwarz C, Thier P. Lurcher mice exhibit potentiation of GABA(A)-receptor-mediated conductance in cerebellar nuclei neurons in close temporal relationship to Purkinje cell death. J Neurophysiol. 2004;91:1102–7.PubMedCrossRefGoogle Scholar
  39. 39.
    The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell. 1994;78:23–33.Google Scholar
  40. 40.
    Kooy RF, D’Hooge R, Reyniers E, Bakker CE, Nagels G, De Boulle K, et al. Transgenic mouse model for the fragile X syndrome. Am J Med Genet. 1996;64:241–5.PubMedCrossRefGoogle Scholar
  41. 41.
    D’Hooge R, Nagels G, Franck F, Bakker CE, Reyniers E, Storm K, et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 1997;76:367–76.PubMedCrossRefGoogle Scholar
  42. 42.
    Bontekoe CJ, McIlwain KL, Nieuwenhuizen IM, Yuva-Paylor LA, Nellis A, Willemsen R, et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet. 2002;11:487–98.PubMedCrossRefGoogle Scholar
  43. 43.
    Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, et al. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011;2:2.PubMedCrossRefGoogle Scholar
  44. 44.
    Sabaratnam M. Pathological and neuropathological findings in two males with fragile-X syndrome. J Intellect Disabil Res. 2000;44:81–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Hallahan B, Daly EM, McAlonan G, Loth E, Toal F, O’Brien F, et al. Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults. Psychol Med. 2009;39:337–46.PubMedCrossRefGoogle Scholar
  46. 46.
    McKelvey JR, Lambert R, Mottron L, Shevell MI. Right-hemisphere dysfunction in Asperger’s syndrome. J Child Neurol. 1995;10:310–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Yu KK, Cheung C, Chua SE, McAlonan GM. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J Psychiatry Neurosci. 2011;36:412–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Murakami JW, Courchesne E, Haas RH, Press GA, Yeung-Courchesne R. Cerebellar and cerebral abnormalities in Rett syndrome: a quantitative MR analysis. Am J Roentgenol. 1992;159:177–83.CrossRefGoogle Scholar
  49. 49.
    Oldfors A, Sourander P, Armstrong DL, Percy AK, Witt-Engerström I, Hagberg BA. Rett syndrome: cerebellar pathology. Pediatr Neurol. 1990;6:310–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Carper RA, Courchesne E. Localized enlargement of the frontal lobe in autism. Biol Psychiatry. 2005;57:126–33.PubMedCrossRefGoogle Scholar
  51. 51.
    Kumar A, Sundaram SK, Sivaswamy L, Behen ME, Makki MI, Ager J, et al. Alterations in frontal lobe tracts and corpus callosum in young children with autism spectrum disorder. Cereb Cortex. 2010;20:2103–13.PubMedCrossRefGoogle Scholar
  52. 52.
    Carper RA, Courchesne E. Inverse correlation between frontal lobe and cerebellum sizes in children with autism. Brain. 2000;123:836–44.PubMedCrossRefGoogle Scholar
  53. 53.
    Hardan AY, Girgus RR, Adams J, Gilbert AR, Keshaven MS, Minshew NJ. Abnormal brain size effect on the thalamus in autism. Psychiatry Res. 2006;147:145–51.PubMedCrossRefGoogle Scholar
  54. 54.
    Tamura R, Kitamura H, Endo T, Hasegawa N, Someya T. Reduced thalamic volume observed across different subgroups of autism spectrum disorders. Psychiatry Res. 2010;184:186–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Tsatsanis KD, Rourke BP, Klin A, Colkmar FR, Cicchetti D, Schultz RT. Reduced thalamic volume in high-functioning individuals with autism. Biol Psychiatry. 2003;53:121–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Estes A, Shaw DW, Sparks BF, Friedman S, Giedd JN, Dawson G, et al. Basal ganglia morphometry and repetitive behavior in young children with autism spectrum disorder. Autism Res. 2011;4:212–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM. Low medial prefrontal dopaminergic activity in autistic children. Lancet. 1997;350:638.PubMedCrossRefGoogle Scholar
  58. 58.
    Aalto S, Brüch A, Laine M, Rinne J. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci. 2005;25:2471–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Gamo NJ, Wang M, Arnsten AF. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry. 2010;49:1011–23.PubMedCrossRefGoogle Scholar
  60. 60.
    Jackson ME, Moghaddam B. Stimulus-specific plasticity of prefrontal cortex dopamine neurotransmission. J Neurochem. 2004;88:1327–34.PubMedCrossRefGoogle Scholar
  61. 61.
    Rose J, Schiffer A-M, Dittrich L, Güntürkün O. The roles of dopamine in maintenance and distractibility of attention in the “prefrontal cortex” of pigeons. Neuroscience. 2010;167:232–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Reader TA, Strazielle C, Botez MI, Lalonde R. Brain dopamine and amino acid concentrations in Lurcher mutant mice. Brain Res Bull. 1998;15:489–93.CrossRefGoogle Scholar
  63. 63.
    Strazielle C, Lalonde R, Amdiss F, Botez MI, Hébert C, Reader TA. Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography. Neurochem Int. 1998;32:61–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Myslivecek J, Cendelín J, Korelusová I, Kunová M, Markvartová V, Vozeh F. Changes of dopamine receptors in mice with olivocerebellar degeneration. Prague Med Rep. 2007;108:57–66.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Tiffany D. Rogers
    • 1
  • Price E. Dickson
    • 1
  • Eric McKimm
    • 1
  • Detlef H. Heck
    • 2
  • Dan Goldowitz
    • 3
  • Charles D. Blaha
    • 1
  • Guy Mittleman
    • 1
  1. 1.Department of PsychologyUniversity of MemphisMemphisUSA
  2. 2.Department of Anatomy & NeurobiologyUniversity of Tennessee Health Science CenterMemphisUSA
  3. 3.Centre for Molecular Medicine & Therapeutics, Department of Medical GeneticsUniversity of British ColumbiaVancouverCanada

Personalised recommendations